Dr. Ozlem Goker-Alpan is the founder and CEO of LDRTC. Dr. Goker-Alpan founded LDRTC in 2013 with a vision to provide high quality care for individuals with lysosomal storage disorders and other rare diseases by utilizing a variety of clinical treatment protocols, multi-specialty clinics and research protocols. Dr. Goker-Alpan received her MD degree in 1990 from Marmara University School of Medicine in Istanbul, Turkey with the highest honors as first in her class. She trained in Pediatrics and then served as a Pediatric Chief Resident at SUNY at Stony Brook, New York. She completed her first fellowship in Clinical and Biochemical Genetics at the National Institutes of Health, Greater Washington Medical Genetics Program in 1999, and worked as an adjunct scientist at the National Child Health Institute. Her second fellowship focused on Lysosomal Storage Disorders and Gaucher disease at the Clinical Neuroscience Branch, NIMH. She coordinated the NIH Gaucher Clinic at the Medical Genetics Branch of the National Human Genome Research Institute until her departure from the NIH in December, 2009. Currently, Dr. Goker-Alpan is also the chief medical officer of the Infusion unit at O&O Alpan, LLC in Fairfax, VA.